General Statement of Disclosure:
CONSULTING FEES/HONORARIA: BridgeBio(MODEST), Ionis(MODEST), Astra Zeneca(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Pfizer Inc(MODEST) SPEAKER'S BUREAU: Pfizer Inc(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Intellia(MODEST), Alexion(MODEST) OTHER FINANCIAL BENEFIT: Life Molecular Imaging(MODEST), Attralus(NONE)
